JP2014501765A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014501765A5 JP2014501765A5 JP2013546457A JP2013546457A JP2014501765A5 JP 2014501765 A5 JP2014501765 A5 JP 2014501765A5 JP 2013546457 A JP2013546457 A JP 2013546457A JP 2013546457 A JP2013546457 A JP 2013546457A JP 2014501765 A5 JP2014501765 A5 JP 2014501765A5
- Authority
- JP
- Japan
- Prior art keywords
- water
- soluble non
- compound
- poly
- peptide polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 37
- 229920000642 polymer Polymers 0.000 claims description 34
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 33
- 125000006850 spacer group Chemical group 0.000 claims description 30
- 150000003839 salts Chemical class 0.000 claims description 14
- 125000006242 amine protecting group Chemical group 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000000178 monomer Substances 0.000 claims description 4
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 125000005647 linker group Chemical group 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 229920000768 polyamine Polymers 0.000 claims description 2
- 229920005862 polyol Polymers 0.000 claims description 2
- 150000003077 polyols Chemical class 0.000 claims description 2
- 229920006295 polythiol Polymers 0.000 claims description 2
- 150000003568 thioethers Chemical class 0.000 claims description 2
- 150000003573 thiols Chemical class 0.000 claims description 2
- 229920003169 water-soluble polymer Polymers 0.000 claims description 2
- 239000002147 L01XE04 - Sunitinib Substances 0.000 claims 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 claims 1
- 235000013877 carbamide Nutrition 0.000 claims 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical group CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 claims 1
- 229960001796 sunitinib Drugs 0.000 claims 1
- 150000003672 ureas Chemical class 0.000 claims 1
- 0 CCCC(C)C(C)(*)***N(CC)CCNC(c1c(C)[n]c(C=C(c(cc(cc2)F)c2N2)C2=O)c1C)=O Chemical compound CCCC(C)C(C)(*)***N(CC)CCNC(c1c(C)[n]c(C=C(c(cc(cc2)F)c2N2)C2=O)c1C)=O 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061426893P | 2010-12-23 | 2010-12-23 | |
| US61/426,893 | 2010-12-23 | ||
| PCT/US2011/067240 WO2012088522A1 (en) | 2010-12-23 | 2011-12-23 | Polymer-des-ethyl sunitinib conjugates |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014501765A JP2014501765A (ja) | 2014-01-23 |
| JP2014501765A5 true JP2014501765A5 (enExample) | 2014-12-25 |
| JP6009457B2 JP6009457B2 (ja) | 2016-10-19 |
Family
ID=45496320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013546457A Active JP6009457B2 (ja) | 2010-12-23 | 2011-12-23 | ポリマー−デスエチルスニチニブコンジュゲート |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US10220020B2 (enExample) |
| EP (1) | EP2654797B1 (enExample) |
| JP (1) | JP6009457B2 (enExample) |
| WO (1) | WO2012088522A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9827326B2 (en) | 2010-12-23 | 2017-11-28 | Nektar Therapeutics | Polymer-sunitinib conjugates |
| WO2012088506A1 (en) | 2010-12-23 | 2012-06-28 | Nektar Therapeutics | Polymer-semaxanib moiety conjugates |
| EP2654797B1 (en) | 2010-12-23 | 2017-11-08 | Nektar Therapeutics | Polymer-des-ethyl sunitinib conjugates |
| US9295731B2 (en) * | 2013-04-01 | 2016-03-29 | Mark Quang Nguyen | Cleavable drug conjugates, compositions thereof and methods of use |
| DK3039424T3 (da) | 2013-08-28 | 2020-08-31 | Crown Bioscience Inc Taicang | Genekspressionssignaturer, der er prædiktive for et individs respons på en multikinaseinhibitor, og fremgangsmåder til anvendelse af disse |
| ES2910659T3 (es) * | 2014-12-04 | 2022-05-13 | Delta Fly Pharma Inc | Nuevo derivado de PEG |
| MA42953A (fr) | 2015-09-22 | 2018-08-01 | Graybug Vision Inc | Composés et compositions pour le traitement de troubles oculaires |
| WO2018175922A1 (en) | 2017-03-23 | 2018-09-27 | Graybug Vision, Inc. | Drugs and compositions for the treatment of ocular disorders |
| MX2019013363A (es) | 2017-05-10 | 2020-01-13 | Graybug Vision Inc | Microparticulas de liberacion extendida y suspensiones de las mismas para terapia medica. |
| CN111995513B (zh) * | 2019-05-27 | 2022-11-01 | 天津键凯科技有限公司 | 一种9-羟甲基-芴二酸的制备方法 |
| GB201916046D0 (en) * | 2019-11-04 | 2019-12-18 | Amazentis Sa | Diagnostic method |
| WO2022103983A2 (en) * | 2020-11-11 | 2022-05-19 | Sutro Biopharma, Inc. | Fluorenylmethyloxycarbonyl and fluorenylmethylaminocarbonyl compounds, protein conjugates thereof, and methods for their use |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4992540A (en) | 1984-11-28 | 1991-02-12 | Massachusetts Institute Of Technology | Glucan composition and process for preparation thereof |
| US4810646A (en) | 1984-11-28 | 1989-03-07 | Massachusetts Institute Of Technology | Glucan compositions and process for preparation thereof |
| US5028703A (en) | 1988-03-11 | 1991-07-02 | Massachusetts Institute Of Technology | Glucan composition and process for preparation thereof |
| US5032401A (en) | 1989-06-15 | 1991-07-16 | Alpha Beta Technology | Glucan drug delivery system and adjuvant |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| MXPA02006263A (es) | 1999-12-22 | 2004-02-26 | Sugen Inc | Metodos de modulacion de la funcion de la cinasa de tirosina c-kit de la proteina con compuestos de indolinona. |
| BRPI0117360B8 (pt) | 2000-02-15 | 2021-07-06 | Upjohn Co | inibidores de proteína de quinase de 2-indolinona de pirrol substituído, seus sais e composições farmacêuticas compreendendo os mesmos |
| EP1299355A2 (en) | 2000-05-02 | 2003-04-09 | Sugen, Inc. | (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| MY128450A (en) | 2000-05-24 | 2007-02-28 | Upjohn Co | 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| TWI259081B (en) * | 2001-10-26 | 2006-08-01 | Sugen Inc | Treatment of acute myeloid leukemia with indolinone compounds |
| CA2466027C (en) | 2001-11-07 | 2013-01-08 | Nektar Therapeutics Al, Corporation | Branched polymers and their conjugates |
| US7053144B1 (en) | 2002-06-13 | 2006-05-30 | Cmi Rubber Company, Inc. | High density rubber compounds |
| US20050079155A1 (en) | 2003-03-20 | 2005-04-14 | Xencor, Inc. | Generating protein pro-drugs using reversible PPG linkages |
| US7887789B2 (en) | 2003-05-23 | 2011-02-15 | Nektar Therapeutics | Polymer derivatives having particular atom arrangements |
| JP5632119B2 (ja) | 2003-09-17 | 2014-11-26 | ウェルズ ファーゴ バンク ナショナル アソシエイション | 多分岐ポリマーのプロドラッグ |
| WO2005107815A2 (en) | 2004-05-03 | 2005-11-17 | Nektar Therapeutics Al, Corporation | Polymer derivatives comprising an imide branching point |
| WO2005108463A2 (en) | 2004-05-03 | 2005-11-17 | Nektar Therapeutics Al, Corporation | Branched polyethylen glycol derivates comprising an acetal or ketal branching point |
| US7740861B2 (en) | 2004-06-16 | 2010-06-22 | University Of Massachusetts | Drug delivery product and methods |
| HUE025208T2 (en) | 2005-06-16 | 2016-03-29 | Nektar Therapeutics | Conjugates with degradable binding and polymer reagents useful in the preparation of such conjugates |
| JP5312050B2 (ja) | 2006-02-21 | 2013-10-09 | ネクター セラピューティクス | 分割型の分解性重合体とそれから生成される複合体 |
| US20080044438A1 (en) | 2006-03-17 | 2008-02-21 | Ostroff Gary R | Yeast Cell Particles As Oral Delivery Vehicles For Antigens |
| CA2671676C (en) | 2006-12-27 | 2014-04-22 | Baxter Healthcare Sa | Von willebrand factor-and factor viii-polymer conjugates having a releasable linkage |
| AU2008331868B2 (en) | 2007-11-28 | 2015-02-12 | Nektar Therapeutics | Oligomer-tricyclic conjugates |
| EP2254601B1 (en) | 2008-02-08 | 2019-05-29 | Nektar Therapeutics | Oligomer-cannabinoid conjugates |
| CN101998866A (zh) | 2008-04-11 | 2011-03-30 | 尼克塔治疗公司 | 低聚物-芳氧基-取代的丙胺共轭物 |
| US8658149B2 (en) | 2008-05-22 | 2014-02-25 | Ramot At Tel-Aviv University Ltd. | Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases |
| KR101671537B1 (ko) | 2008-08-11 | 2016-11-01 | 넥타르 테라퓨틱스 | 다분지형 중합체 알카노에이트 컨쥬게이트 |
| US20120052041A1 (en) * | 2009-02-04 | 2012-03-01 | The Brigham And Women's Hospital, Inc. | Polymeric nanoparticles with enhanced drug-loading and methods of use thereof |
| WO2010120387A1 (en) | 2009-04-17 | 2010-10-21 | Nektar Therapeutics | Oligomer-protein tyrosine kinase inhibitor conjugates |
| US8816077B2 (en) | 2009-04-17 | 2014-08-26 | Nektar Therapeutics | Oligomer-protein tyrosine kinase inhibitor conjugates |
| EP2654797B1 (en) | 2010-12-23 | 2017-11-08 | Nektar Therapeutics | Polymer-des-ethyl sunitinib conjugates |
| US9827326B2 (en) | 2010-12-23 | 2017-11-28 | Nektar Therapeutics | Polymer-sunitinib conjugates |
| US20140331425A1 (en) | 2013-05-09 | 2014-11-13 | DeAndre Charles Baker | Sqeeky kleen toilet brush |
-
2011
- 2011-12-23 EP EP11809055.4A patent/EP2654797B1/en active Active
- 2011-12-23 WO PCT/US2011/067240 patent/WO2012088522A1/en not_active Ceased
- 2011-12-23 US US13/995,819 patent/US10220020B2/en active Active
- 2011-12-23 JP JP2013546457A patent/JP6009457B2/ja active Active
-
2019
- 2019-01-09 US US16/243,914 patent/US11406618B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014501765A5 (enExample) | ||
| JP2014503548A5 (enExample) | ||
| ES2254717T3 (es) | Copolimeros de bloque multi-brazo y composiciones farmaceuticas. | |
| AU2008317383B2 (en) | Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom | |
| JP5655147B2 (ja) | 治療用ペプチド−ポリマーの複合体、粒子、組成物および関連の方法 | |
| JP2002508400A5 (enExample) | ||
| AU2007216998B8 (en) | Segmented degradable polymers and conjugates made therefrom | |
| JP2012502904A5 (enExample) | ||
| JP2011080089A5 (enExample) | ||
| JP2011528654A5 (enExample) | ||
| JP2017511322A5 (enExample) | ||
| US20100004390A1 (en) | Biodegradable metal-chelating polymers and vaccines | |
| JP2010523582A5 (enExample) | ||
| JP2010527913A5 (enExample) | ||
| JP2014058562A5 (enExample) | ||
| JP2008523239A5 (enExample) | ||
| JP2007504169A5 (enExample) | ||
| JP2008266635A5 (ja) | 活性エネルギー線硬化型液体組成物、水性インク及び液体カートリッジ | |
| JP2004532301A5 (enExample) | ||
| JP2012516347A5 (enExample) | ||
| UA93284C2 (uk) | Поліетиленгліколь-g-csf кон'югат | |
| JP2012530069A (ja) | プロテアーゼ阻害剤、水溶性非ペプチドオリゴマーおよび親油性部分を含む共有結合体 | |
| US12403199B2 (en) | Asymmetrically branched degradable polyethylene glycol derivative | |
| JP2015529686A5 (enExample) | ||
| HK1183804A (en) | Therapeutic peptide-polymer conjugates, particles, compositions, and related methods |